Formaldehyde

Formaldehyde

SCHEMBL1471574

Brc1ccccc1NCCNCc1cccc(N2CCCCC2)c1.C=O

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRMT6 Q96LA8 1/20 0.50
HDAC4 P56524 4/20 0.41
MEF2D Q14814 4/20 0.41
AGXT P21549 1/20 0.40
MAPT P10636 4/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
KMT2A Q03164 2/20 0.39
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 1/20 0.39
USP2 O75604 1/20 0.39
ALDH1A1 P00352 1/20 0.39
POLB P06746 1/20 0.39
HPGD P15428 1/20 0.39
BLM P54132 1/20 0.39
MAP4K4 O95819 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formaldehyde SCHEMBL1471009 0.83 MAPT (0.56) PRMT6MAPTCYP1A2CYP3A4CYP2C9
SCHEMBL1471422 0.80 PRMT6 (0.53) PRMT6HDAC4MEF2DAGXTMAPT
SCHEMBL1471433 0.78 HPGD (0.47) MAPTKMT2AMEN1ALDH1A1POLB
SCHEMBL1471583 0.73 HTR1A (0.35) MAPTNPSR1KMT2AMEN1SMN1; SMN2
SCHEMBL30854955 0.69 FABP1 (0.56) PRMT6HDAC4MEF2DAGXTMAPT
SCHEMBL30438836 0.69 PRMT6 (0.63) PRMT6HDAC4MEF2DAGXTMAPT
SCHEMBL1036548 0.68 PRMT6 (1.00) PRMT6HDAC4MEF2DAGXTMAPT
SCHEMBL5621913 0.66 PRMT6 (0.97) PRMT6HDAC4MEF2DAGXTMAPT
SCHEMBL8305984 0.66 RAB9A (0.53) MAPTKMT2AMEN1USP2ALDH1A1
SCHEMBL1470949 0.66 RAB9A (0.47) MAPTKMT2AMEN1ALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7915420-B2 Aryl piperidine amides JANSSEN PHARMACEUTICA NV (BE) 2011-03-29 US disclosed
US-20080009521-A1 Aryl Piperidine Amides HUANG CHARLES Q 2008-01-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080009521-A1 Aryl Piperidine Amides BDNF, NTRK2, OPRL1 PRMT6 1303/4885HDAC4 324/4885MEF2D 3256/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.